![]() |
|
|
Department of Life Science, College of Agriculture, Meiji University, Higashimita, Tama-ku, Kawasaki 214-8571, Japan
3To whom correspondence should be addressed. E-mail: hino{at}isc.meiji.ac.jp.
ABSTRACT
Butyrivibrio fibrisolvens, a butyrate-producing ruminal bacterium, was evaluated for use as a probiotic to prevent colorectal cancer. Oral administration to Jcl:ICR mice of a new strain of B. fibrisolvens (MDT-1) that produces butyrate at a high rate (109 cfu/dose) increased the rate of butyrate production by fecal microbes, suggesting that MDT-1 can grow in the gut. The number of colorectal aberrant crypt foci (ACF), putative preneoplastic lesions induced by 1,2-dimethylhydrazine, was reduced after MDT-1 administration (109 cfu/dose, 3 times/wk for 4 wk). The number of aberrant crypts (ACs), number of foci having 3 or 4 ACs per focus, and the percentage of mice having 3 or 4 ACs per focus were also reduced, suggesting that the progress of lesions was suppressed by MDT-1. Interestingly, the MDT-1 cell homogenate did not have a similar beneficial effect. MDT-1 had low ß-glucuronidase activity, and administration of MDT-1 reduced the ß-glucuronidase activity in the colorectal contents. The numbers of natural killer (NK) and NKT cells in the spleen were markedly enhanced in response to MDT-1. Decreased ß-glucuronidase activity and increased numbers of NK and NKT cells and butyrate production may explain in part why MDT-1 administration suppressed ACF formation. These results suggest that colorectal cancer may be prevented or suppressed by the utilization of MDT-1 as a probiotic. Administration of MDT-1 had no harmful effect on the health of mice at least for 3 mo.
KEY WORDS: Butyrivibrio fibrisolvens intestinal bacteria probiotic colon cancer butyrate
This article has been cited by other articles:
![]() |
M. S. Gomez-Conde, J. Garcia, S. Chamorro, P. Eiras, P. G. Rebollar, A. Perez de Rozas, I. Badiola, C. de Blas, and R. Carabano Neutral detergent-soluble fiber improves gut barrier function in twenty-five-day-old weaned rabbits J Anim Sci, December 1, 2007; 85(12): 3313 - 3321. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ohkawara, H. Furuya, K. Nagashima, N. Asanuma, and T. Hino Effect of Oral Administration of Butyrivibrio fibrisolvens MDT-1 on Experimental Enterocolitis in Mice Clin. Vaccine Immunol., November 1, 2006; 13(11): 1231 - 1236. [Abstract] [Full Text] [PDF] |
||||